Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (20)

2024

  1. Does the Prevalence of Obesity in the Different Regions of Spain Influence the Attitudes, Perception, and Barriers to Its Treatment?

    Obesity Facts, Vol. 17, Núm. 3, pp. 264-273

  2. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

  3. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 4, pp. 1157-1170

2023

  1. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  2. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations

    PloS one, Vol. 18, Núm. 7, pp. e0287515

2022

  1. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document “Treatment of type 2 diabetes mellitus in the elderly”

    Revista Clinica Espanola, Vol. 222, Núm. 8, pp. 496-499

  2. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study

    European Eating Disorders Review

  2. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

    FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837

2019

  1. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function

    FASEB Journal, Vol. 33, Núm. 8, pp. 9656-9671

  2. Preoperative circulating succinate levels as a biomarker for diabetes remission after bariatric surgery

    Diabetes Care, Vol. 42, Núm. 10, pp. 1956-1965

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

  2. Consensus on insulin treatment in type 2 diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 1-8

  3. Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 10, pp. 611-624

2016

  1. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study

    Medicina Clinica, Vol. 146, Núm. 6, pp. 239-246

2014

  1. Loss of control over eating: A description of the eating disorder/obesity spectrum in women

    European Eating Disorders Review, Vol. 22, Núm. 1, pp. 25-31

2013

  1. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

    Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537

  2. Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations

    PLoS ONE, Vol. 8, Núm. 3

2012

  1. Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide y and proopiomelanocortin expression in nondiabetic and diabetic IRS2 -/- mice

    Endocrinology, Vol. 153, Núm. 3, pp. 1129-1140